TMO
NYSETHERMO FISHER SCIENTIFIC INC.
Health Care, Life Sciences Tools & Services
$594.00
close 7 Aug 2026
+28.46%
52-week change
$219.63B
market cap
$435.27
$643.99
52-week range
Valuation
Market cap$219.63B
P/E (TTM / 5y avg)31.95x31.53x
Forward P/E (FY2026 / FY2027)23.65x21.59x
PEG (TTM / fwd)153.952.48
P/S (TTM)4.74x
P/B4.17x
EV/EBITDA (TTM)27.75x
FCF yield (TTM)3.33%
Cash flow & dividend
FCF (TTM)$7.32B
FCF per share (TTM)$19.79
FCF margin (TTM)15.79%
Dividend yield (indicated / 5y avg)0.32%0.27%
Annualized dividend$1.88
Payout ratio (EPS / FCF)9.50%9.05%
Growth & quality
Revenue YoY, latest Q+10.49%
Diluted EPS YoY, latest Q+9.35%
Operating margin (TTM)17.58%
Net margin (TTM)15.04%
ROE (latest FY)12.55%
Net debt / EBITDA (TTM)4.14
Interest coverage (TTM)5.55
Price
+9.06%+1.76%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +6.70%10Y CAGR +10.14%
Diluted EPS
5Y CAGR +2.14%10Y CAGR +13.68%
FCF per share
5Y CAGR -0.48%10Y CAGR +10.25%
Operating cash flow
5Y CAGR -1.16%10Y CAGR +10.27%
Free cash flow
5Y CAGR -1.58%10Y CAGR +9.59%
Dividends per share
5Y CAGR +14.82%10Y CAGR +10.86%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -1.11%10Y CAGR -0.60%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date20 Oct 2026bmo
EPS estimate$6.48
Revenue estimate$12.07B
Last reported
Date—
EPS——
Revenue——